(19)
(11) EP 2 136 638 A1

(12)

(43) Date of publication:
30.12.2009 Bulletin 2009/53

(21) Application number: 08743922.0

(22) Date of filing: 14.03.2008
(51) International Patent Classification (IPC): 
A01N 43/78(2006.01)
A61K 31/425(2006.01)
(86) International application number:
PCT/US2008/057059
(87) International publication number:
WO 2008/113003 (18.09.2008 Gazette 2008/38)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA MK RS

(30) Priority: 14.03.2007 US 894799 P
14.03.2007 US 894829 P
14.03.2007 US 894814 P
14.03.2007 US 894835 P
10.10.2007 US 979049 P
14.12.2007 US 957157

(71) Applicant: Knopp Neurosciences, Inc.
Pittsburgh PA 15203 (US)

(72) Inventors:
  • BOZIK, Michael, E.
    Pittsburgh, Pennsylvania 15237 (US)
  • GRIBKOFF, Valentin
    Wallingford, Connecticut 06492 (US)
  • PETZINGER, Thomas, Jr.
    Pittsburgh, Pennsylvania 15219 (US)

(74) Representative: Ouzman, Beverley Nicola Claire et al
Murgitroyd & Company 165-169 Scotland Street
GB-Glasgow G5 8PL
GB-Glasgow G5 8PL (GB)

   


(54) MODIFIED RELEASE FORMULATIONS OF (6R)-4,5,6,7-TETRAHYDRO-N6-PROPYL-2,6-BENZOTHIAZOLE-DIAMINE AND METHODS OF USING THE SAME